N.V. Innogenetics S.A.
43Patents
3Active
43Granted
36Portfolio score
Filing activity: Oct 4, 1993 → Nov 10, 2008 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5736524A | Polynucleotide tuberculosis vaccine | Human Necessities | 128 | Expired |
| US6238892A | Monoclonal antibodies directed against the microtubule-associated protein tau | Emerging Cross-Sectional Technologies | 50 | Expired |
| US5733879A | Peptides and proteins, process for their preparation and their use as cholesterol acceptors | Human Necessities | 34 | Expired |
| US5846704A | Process for typing of HCV isolates | Chemistry; Metallurgy | 31 | Expired |
| US6010913A | Isolated human tau peptide | Emerging Cross-Sectional Technologies | 30 | Expired |
| US5536638A | Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae | Chemistry; Metallurgy | 29 | Expired |
| US5843779A | Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies | Chemistry; Metallurgy | 28 | Expired |
| US6110670A | Nucleotide sequences, probes and a process for the in vitro diagnosis of chromosomal anomalies correlated with CMT1A disease | Chemistry; Metallurgy | 25 | Expired |
| US6232437A | Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120. | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6900293B2 | Monoclonal antibodies directed against the microtubule-associated protein tau | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5891640A | Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays | Physics | 13 | Expired |
| US5861257A | Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6585969B1 | Non-viable keratinocyte cell composition or lysate for promoting wound healing | Emerging Cross-Sectional Technologies | 11 | Expired |
| US8163873B2 | Isolated microtubule-associated protein tau peptides and kit | Emerging Cross-Sectional Technologies | 11 | Active |
| US6051696A | Process for typing of HCV isolates | Chemistry; Metallurgy | 10 | Expired |
| US7122306B2 | Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents | Chemistry; Metallurgy | 9 | Expired |
| US6171784A | Process for typing of HCV isolates | Chemistry; Metallurgy | 9 | Expired |
| US5945282A | Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms | Chemistry; Metallurgy | 8 | Expired |
| US5981277A | Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology | Chemistry; Metallurgy | 8 | Expired |
| US6277577A | Hybridization probes derived from the spacer region between the 16s and 23s RRNA genes for the detection of non-viral microorganisms | Chemistry; Metallurgy | 8 | Expired |
| US6165730A | Hepatitis C virus peptides obtained from the NS4 coding region and their use in diagnostic assays | Physics | 8 | Expired |
| US6126935A | Pellets obtained from cell cultures of keratinocytes and their use in wound healing | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5916558A | Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis | Human Necessities | 7 | Expired |
| US5955356A | Nucleic acids, vectors, and host cells including mycobacterium derived sequences | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6667387B1 | HCV core peptides | Physics | 6 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.